Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value: $1.665B (100.0% shares, 0.0% debt)

Holdings (41)

— IMMUNOMEDICS INC 11.0%
Value $184M Shares 5,182,983 Share Price $35.44 Est. Cost/Share $13.38 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 10.4%
Value $174M Shares 2,821,154 Share Price $61.54 * Est. Cost/Share $13.06 Unrealized @ Report Date +212.8%
BMRN BIOMARIN PHARMACEUTICAL INC 10.4%
Value $173M Shares 1,405,950 Share Price $123.34 * Est. Cost/Share $80.19 Unrealized @ Report Date +23.9%
INSM INSMED INC 9.9%
Value $165M Shares 6,002,289 Share Price $27.54 * Est. Cost/Share $17.16 Unrealized @ Report Date +38.1%
— ABIOMED INC 7.1%
Value $119M Shares 492,333 Share Price $241.56 Est. Cost/Share $37.80 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 6.6%
Value $111M Shares 7,334,714 Share Price $15.08 * Est. Cost/Share $7.59 Unrealized @ Report Date +60.5%
UTHR UNITED THERAPEUTICS CORP 5.6%
Value $92.73M Shares 766,406 Share Price $121.00 * Est. Cost/Share $88.73 Unrealized @ Report Date +26.8%
— EPIZYME INC 5.3%
Value $88.55M Shares 5,513,676 Share Price $16.06 Est. Cost/Share $15.12 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 4.8%
Value $79.92M Shares 4,219,452 Share Price $18.94 Est. Cost/Share $17.42 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 4.6%
Value $75.85M Shares 1,564,900 Share Price $48.47 Est. Cost/Share $27.34 Unrealized @ Report Date +75.6%
— AIMMUNE THERAPEUTICS INC 3.3%
Value $55.45M Shares 3,318,212 Share Price $16.71 Est. Cost/Share $22.84 Unrealized @ Report Date —
— ALEXION PHARMACEUTICALS INC 3.0%
Value $49.91M Shares 444,629 Share Price $112.24 Est. Cost/Share $121.54 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 3.0%
Value $49.22M Shares 1,479,524 Share Price $33.27 Est. Cost/Share $14.06 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 2.8%
Value $47.09M Shares 4,116,548 Share Price $11.44 Est. Cost/Share $11.21 Unrealized @ Report Date +1.0%
— REVANCE THERAPEUTICS INC 2.5%
Value $41.62M Shares 1,704,372 Share Price $24.42 Est. Cost/Share $21.02 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 1.8%
Value $29.44M Shares 4,361,411 Share Price $6.75 Est. Cost/Share $48.59 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 1.4%
Value $23.92M Shares 575,200 Share Price $41.58 Est. Cost/Share $48.62 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 1.4%
Value $22.64M Shares 2,959,587 Share Price $7.65 Est. Cost/Share $29.07 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 1.1%
Value $18.53M Shares 67,505 Share Price $274.44 * Est. Cost/Share $114.31 Unrealized @ Report Date +97.0%
PBYI PUMA BIOTECHNOLOGY INC 0.8%
Value $14.02M Shares 1,343,897 Share Price $10.43 Est. Cost/Share $28.26 Unrealized @ Report Date -63.4%
— DICERNA PHARMACEUTICALS INC 0.5%
Value $8.428M Shares 331,813 Share Price $25.40 Est. Cost/Share $5.39 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 0.5%
Value $8.065M Shares 771,065 Share Price $10.46 * Est. Cost/Share $32.98 Unrealized @ Report Date -66.3%
— RIGEL PHARMACEUTICALS INC 0.4%
Value $6.483M Shares 3,542,551 Share Price $1.83 Est. Cost/Share $3.40 Unrealized @ Report Date —
KLDO KALEIDO BIOSCIENCES INC 0.4%
Value $5.843M Shares 786,400 Share Price $7.43 * Est. Cost/Share $13.76 Unrealized @ Report Date -51.3%
CYTK CYTOKINETICS INC 0.2%
Value $2.915M Shares 123,686 Share Price $23.57 * Est. Cost/Share $6.71 Unrealized @ Report Date +179.3%
— ZOGENIX INC 0.2%
Value $2.812M Shares 104,100 Share Price $27.01 Est. Cost/Share $23.14 Unrealized @ Report Date —
GOSS GOSSAMER BIO INC 0.2%
Value $2.655M Shares 204,214 Share Price $13.00 * Est. Cost/Share $12.58 Unrealized @ Report Date 0.0%
— ATHENEX INC 0.2%
Value $2.548M Shares 185,200 Share Price $13.76 Est. Cost/Share $13.76 Unrealized @ Report Date —
SNDX SYNDAX PHARMACEUTICALS INC 0.1%
Value $1.893M Shares 127,700 Share Price $14.82 * Est. Cost/Share $12.20 Unrealized @ Report Date +24.8%
— APREA THERAPEUTICS INC 0.1%
Value $1.832M Shares 47,234 Share Price $38.79 Est. Cost/Share $38.79 Unrealized @ Report Date —
— MAGENTA THERAPEUTICS INC 0.1%
Value $1.461M Shares 194,600 Share Price $7.51 Est. Cost/Share $7.51 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.1%
Value $1.266M Shares 200,919 Share Price $6.30 Est. Cost/Share $6.30 Unrealized @ Report Date —
— KEZAR LIFE SCIENCES INC 0.1%
Value $1.062M Shares 205,086 Share Price $5.18 Est. Cost/Share $5.18 Unrealized @ Report Date —
— INTRA-CELLULAR THERAPIES INC 0.1%
Value $960K Shares 37,400 Share Price $25.67 Est. Cost/Share $34.30 Unrealized @ Report Date —
— RETROPHIN INC 0.1%
Value $959K Shares 47,000 Share Price $20.40 Est. Cost/Share $14.60 Unrealized @ Report Date —
URGN UROGEN PHARMA LTD 0.0%
Value $640K Shares 24,500 Share Price $26.12 * Est. Cost/Share $27.01 Unrealized @ Report Date -9.5%
— MARINUS PHARMACEUTICALS INC 0.0%
Value $318K Shares 125,321 Share Price $2.54 Est. Cost/Share $4.17 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.0%
Value $306K Shares 1,162,473 Share Price $0.26 Est. Cost/Share $4.37 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $306K Shares 73,500 Share Price $4.16 * Est. Cost/Share $7.53 Unrealized @ Report Date -51.5%
— IDERA PHARMACEUTICALS INC 0.0%
Value $138K Shares 77,044 Share Price $1.79 Est. Cost/Share $8.90 Unrealized @ Report Date —
— MINERVA NEUROSCIENCES INC 0.0%
Value $131K Shares 36,319 Share Price $3.61 Est. Cost/Share $5.62 Unrealized @ Report Date —